PANCREATIC ACINAR CELL CARCINOMA
Clinical trials for PANCREATIC ACINAR CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC ACINAR CELL CARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC ACINAR CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stem cell combo trial aims to outsmart Drug-Resistant cancers
Disease control Recruiting nowThis early-phase study tests a new treatment for people with metastatic pancreatic or breast cancer that has stopped responding to standard therapies. The treatment combines two chemotherapy drugs with high-dose vitamins and a stem cell transplant to help the body recover. The ma…
Matched conditions: PANCREATIC ACINAR CELL CARCINOMA
Phase: PHASE1 • Sponsor: General Oncology, Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New hope for pancreatic cancer: targeted pill may double remission time
Disease control Recruiting nowThis study tests whether a daily pill called olaparib can keep pancreatic cancer from returning after surgery and chemotherapy. It is for people whose tumors have specific gene mutations (BRCA1, BRCA2, or PALB2). About 152 participants will receive either olaparib or a placebo fo…
Matched conditions: PANCREATIC ACINAR CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:46 UTC